Cargando…
A Novel PAA Derivative with Enhanced Drug Efficacy in Pancreatic Cancer Cell Lines
Nanoparticles have been shown to be effective drug carriers in cancer therapy. Pancreatic cancer forms dense tumours which are often resistant to drug molecules. In order to overcome such multidrug resistance, new drug entities, novel delivery systems and combination therapy strategies are being exp...
Autores principales: | Alsuraifi, Ali, Lin, Paul Kong Thoo, Curtis, Anthony, Lamprou, Dimitrios A., Hoskins, Clare |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315666/ https://www.ncbi.nlm.nih.gov/pubmed/30248980 http://dx.doi.org/10.3390/ph11040091 |
Ejemplares similares
-
Stimuli Responsive Polymeric Systems for Cancer Therapy
por: Alsuraifi, Ali, et al.
Publicado: (2018) -
Dual Acting Polymeric Nano-Aggregates for Liver Cancer Therapy
por: Al-Shakarchi, Wejdan, et al.
Publicado: (2018) -
Combined Effect of Anticancer Agents and Cytochrome C Decorated Hybrid Nanoparticles for Liver Cancer Therapy
por: Al-Shakarchi, Wejdan, et al.
Publicado: (2018) -
Programming for PaaS
por: Carlson, Lucas
Publicado: (2013) -
Understanding PaaS
por: McGrath, Michael
Publicado: (2012)